E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/24/2013 in the Prospect News PIPE Daily.

Rexahn to raise $5.7 million via registered direct offering of units

H.C. Wainwright sells units of one share and a warrant for 0.35 of a share

By Devika Patel

Knoxville, Tenn., July 24 - Rexahn Pharmaceuticals, Inc. said it plans a registered direct offering of units to raise $5.7 million. H.C. Wainwright & Co., LLC is the agent.

The company will sell 11.4 million units of one common share and one warrant for 0.35 of a share at $0.50 per unit, with each whole warrant exercisable at $0.59 for five years.

The strike price is identical to the July 23 closing share price.

Settlement is expected July 26.

Proceeds will be used for general corporate purposes and working capital.

Rexahn is a biopharmaceutical company based in Rockville, Md.

Issuer:Rexahn Pharmaceuticals, Inc.
Issue:Units of one common share and one warrant for 0.35 of a share
Amount:$5.7 million
Units:11.4 million
Price:$0.50
Warrants:One warrant for 0.35 of a share per unit
Warrant expiration:Five years
Warrant strike price:$0.59
Agent:H.C. Wainwright & Co., LLC
Pricing date:July 24
Settlement date:July 26
Stock symbol:NYSE: RNN
Stock price:$0.59 at close July 23
Market capitalization:$63.3 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.